Business Segments · Identifiable assets
Diagnostics — Identifiable assets
Danaher Diagnostics — Identifiable assets increased by 3.8% to $14.75B in Q4 2025 compared to the prior quarter.
Analysis
StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2023
Last reportedQ4 2025
Rolls up toTotal Assets
How to read this metric
Growth in assets relative to sales may indicate declining capital efficiency, while stable assets with growing sales indicate improved efficiency.
Detailed definition
The total value of assets that can be directly attributed to the diagnostics segment, including inventory, property, pla...
Peer comparison
Standard segment-level disclosure for diversified corporations.
Metric ID:
dhr_segment_diagnostics_identifiable_assetsHistorical Data
3 periods
| Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|
| Value | $14.55B | $14.20B | $14.75B |
| QoQ Change | — | -2.4% | +3.8% |
| YoY Change | — | -2.4% | +3.8% |
Range$14.20B – $14.75B
Avg YoY Growth+0.7%
Median YoY Growth+0.7%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Danaher's diagnostics — identifiable assets?
- Danaher (DHR) reported diagnostics — identifiable assets of $14.75B in Q4 2025.
- What does diagnostics — identifiable assets mean?
- The total value of all assets specifically used by the diagnostics segment.